TEL AVIV, Israel, May 30, 2023 /PRNewswire/ -- BioLight (TASE: BOLT) is proud to report it has signed a research collaboration agreement with Alexion (AstraZeneca Rare Disease), focusing on exploring ...

BioLight Life Sciences Investments (OTCQX: BLGTY, TASE:BOLT) ("BioLight" or the "Company"), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer ...

BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today an ...

(RTTNews) - BioLight Life Sciences Ltd. announced Tuesday it has signed a research collaboration agreement with Alexion Pharmaceuticals, Inc. (ALXN), a subsidiary of AstraZeneca plc (AZN, AZN.L), ...

SAN FRANCISCO - September 23, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (MERR), announced today that it will serve as the Principal American Liaison (PAL) for ...

BioLight Israeli Life Sciences Investments Ltd. said Wednesday that it has closed a $4 million private placement with two unnamed institutional investors. This transaction comes on the heels of the ...

BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT)(OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical ...

BioLight Life Sciences Investments Ltd and Aerie Pharmaceuticals Affiliates Announce a Collaboration for Continued Development of a Controlled-Release Ocular Implant for the Delivery of Ophthalmic ...

Find the Guangdong Biolight Meditech financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including ...

BioLight, an innovative company focusing on biohacking, prepares to offer its cutting-edge red light therapy devices in the coming months as it raises funds for its first round. The patent-pending red ...